Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
Quick Find - Click to open on a page
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
Contact Contact Licensing
PODCAST Podcast
RSS RSS

Licensing


Embracing Partnerships

Welcome! At Merck, we are strongly committed to partnership success. We recognize that the greatest achievements are not reached alone. They are the result of teamwork

We are serious about our commitment to strategic alliances. Our goal is to work together with our partners to remain in the forefront of turning scientific breakthroughs into medicines that make a difference.

We have established a clear path to partnering, and we invite you to explore the combining of your
strengths with ours, and the successes
we may share.


Richard T. Clark, Chief Executive Officer and President
“At Merck, partnering is an essential component of our strategy to discover and develop novel medicines that meet major unmet medical needs. We place a premium on our ability to identify the best external opportunities, and to offer the unique talents of both Merck Research Laboratories and of our Sales and Marketing organizations to bring your ideas to the patients who need them.”

Richard T. Clark
Chief Executive Officer and President


Mervyn Turner, Ph.D. Senior Vice President of Worldwide licensing and External Research“Most of the world’s biomedical research takes place outside of our laboratories, so we charge our scientists with building a 'virtual lab' – the blending of the best scientific programs from internal research and external collaborations. We want to help you take your great science and turn it into great medicine. We want to help you make a difference in the lives of patients all around the world. That’s why we are all in this together.”

Mervyn Turner, Ph.D.
Senior Vice President
Worldwide Licensing and External Research


Barbara Yanni, Chief Licensing Officer“Flexibility and creativity are critical components of our negotiation process. We’re interested in listening to you, to find the best way to bring your discovery through development to market.”

Barbara Yanni
Vice President and Chief Licensing Officer







This Web site contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. more>>

* These files are presented in PDF format.  This software is available at no charge through the Adobe Web site.  Get Adobe Reader
Printer Friendly Page
 

Regional Scouts

A list of our regional scouts and contact information

Face-to-Face

Barbara Yanni
An exclusive interview with Barbara Yanni, Vice President and Chief Licensing Officer at Merck & Co

More Information

Embracing Partnerships, Committed to Partnering Success


Embracing Partnerships

Spotlight on Worldwide Licensing

Innovative ideas, now coming together

Innovative ideas, now
coming together




Scouting around at Merck & Co. Inc.

Scouting around at
Merck & Co., Inc.




Hans BoströmHans Boström, PhD
Director, Licensing and External Research, Europe
 
ANGLO-NORDIC BIOTECH BUSINESS OPPORTUNITIES
Doing business as easy
as ABC
 
Contact Merck Site Map Privacy Policy Terms of Use Copyright 1995-2008 Merck & Co., Inc.